H 50mg / R 75mg, disp. tab., blister
STD
DORAHRIF5TD1
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
07/11/2024, 20:48:00
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
ISONIAZID (H) / RIFAMPICIN (R)
Therapeutic Action
Fixed-dose combination (FDC) of two bactericide antituberculosis drugs
Indications
Drug-Sensitive Tuberculosis (DS-TB)
Latent Tuberculosis Infection (LTI-TB)
Instructions for use
The dosage 50 mg / 75 mg is intended for paediatric use.
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25ºC - Protect from sunlight - Protect from humidity